
Based on the current market situation, the FDA’s expected decision date for the specified application is June 30, 2026. If the U.S. Food and Drug Administration (FDA) grants full or conditional approval for Viridian Therapeutics’ Veligrotug for the treatment of thyroid eye disease by July 14, 2026, 23:59 ET, this market will rule “Yes.” Otherwise, this market will rule “No.” Approval is defined as follows: For new drugs: The FDA granting approval
Platform fee: 2%. Click an option to make a prediction.
%2 platform fee
Select an option above
95% of Polymarket users lose money long-term. The 5% who profit follow systematic strategies. This guide reveals the 10 professional methods used by profitable traders — backed by data, not guesswork.
Kalshi and Polymarket are the two giants of prediction markets in 2026. One is CFTC-regulated and US-only; the other is global, onchain, and Polygon-based. Which is right for you? This deep comparison covers every dimension.
Polymarket'te kullanıcıların %95'i para kaybediyor. Geri kalan %5 ise tutarlı kâr ediyor. Aradaki fark şans değil — disiplinli strateji. Bu rehberde profesyonel trader'ların kullandığı 7 ana yöntemi adım adım anlatıyoruz.